January 8, 2016 10:45am

Dr. Loan Hoang-Sayag was appointed to the role of Chief Medical Officer (CMO).


 

Dr. Hoang-Sayag joins CLLS from Quintiles Transnational, where she was most recently Senior Director of Medical Science.

Dr. Hoang-Sayag is a board-certified physician in hematology and medical oncology with 23 years of experience – eight years in the hospital / university setting and 15 years in oncology clinical development. In her most recent role, she was at Quintiles Transnational for 10 years where she held the positions of Associate Medical Director, Medical Director and Senior Director of Medical Science. Prior to Quintiles, she was at Pierre Fabre Oncology, serving as the oncology project leader in charge of a variety of clinical studies for this France-based pharmaceutical company. Additionally, Dr. Hoang-Sayag was a medical manager at Hoffmann La Roche in France where she was responsible for clinical development and medical affairs activities for several new oncology drugs. Dr. Hoang-Sayag will report to Mathieu Simon, MD, Executive VP and COO of Cellectis.